10x Genomics, Inc. (TXG)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-12) · 99.1 | 8-K (2026-01-12) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-08) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-12) · 99.1 | 8-K (2025-01-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-10-29) · 99.1 | 8-K (2024-10-09) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 · 99.2 | ||
| 10-Q | Q1-2024 | 8-K (2024-04-30) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-15) · 99.1 | 8-K (2024-01-08) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Comprehensive Income (loss) | — |
|
| Consolidated Balance Sheets (P) | — |
|
| Consolidated Statements of Comprehensive Loss | ||
| Consolidated Statements of Stockholders Equity | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Acquisitions | ||
| Asset Acquisition | — |
|
| Capital Stock | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Description of Business and Basis of Presentation | ||
| Employee Benefit Plans | — |
|
| Equity Incentive Plans | ||
| Income Tax | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Net Income (loss) Per Share | — |
|
| Net Loss Per Share | ||
| Other Financial Statement Information | ||
| Pay Vs Performance Disclosure | ||
| Restructuring | ||
| Subsequent Event | — |
|
| Summary of Significant Accounting Policies | ||